Australia's Genetic Signatures urges largest stakeholder to clarify merger intentions; shares rise
BUZZ-Australia's Genetic Signatures urges largest stakeholder to clarify merger intentions; shares rise ** Shares of molecular diagnostics firm Genetic Signatures GSS.AX rise 5% to A$0.084
** GSS Suspects BCAL Diagnostics BDX.AX, its largest shareholder, intends to pursue a merger with co, given respective cash positions of BCAL and GSS
** Calls for BCAL to clarify such intentions
** Stock down 66.4% YTD, including moves in current session
(Reporting by Jasmeen Ara Shaikh in Bengaluru)
Recent news on Genetic Signatures
See all newsBrief: Genetic Signatures Says Microba Shareholders To Hold 60% Of GSS On Merger
Australia's Genetic Signatures urges largest stakeholder to clarify merger intentions; shares rise
Brief: Genetic Signatures Receives Request From BCAL Diagnostics To Call General Meeting Of Shareholders
Brief: Genetic Signatures Requested BCAL Diagnostics To Clarify Details Of Shareholdings, Associates In Co
Brief: Genetic Signatures Announces Board Changes